|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online September 19, 2007
doi: 10.1242/10.1242/jcs.009159
Research Article |
1 Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA
2 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
* Author for correspondence (e-mail: huttenlocher{at}wisc.edu)
Accepted 17 August 2007
| Summary |
|---|
|
|
|---|
Key words: Cell migration, Inflammation, Neutrophil, Psoriasis, Zebrafish
| Introduction |
|---|
|
|
|---|
The zebrafish, Danio rerio, has emerged as a powerful model system to examine mechanisms of human disease because it is a vertebrate that is genetically tractable and is amenable to small molecule screening (Patton and Zon, 2001
; Zon and Peterson, 2005
). The presence of both innate and adaptive immune systems in zebrafish provides support for the utility of zebrafish as a tool to examine the role of immune cells in normal development and in the pathogenesis of disease states (Crowhurst et al., 2002
; de Jong and Zon, 2005
; Langenau and Zon, 2005
; Murayama et al., 2006
; Onnebo et al., 2004
; Trede et al., 2004
). For example, substantial evidence indicates the validity and strength of using zebrafish to examine host-pathogen interactions in vivo in response to mycobacterial (Davis et al., 2002
) or other (van der Sar et al., 2003
) infections that can be observed in real-time because of the optical clarify of zebrafish embryos. Further clarification of these immune responses can be provided by recent advances in the generation of transgenic zebrafish in which specific cell lineages, including lymphocytes (Langenau et al., 2004
), macrophages (Hall et al., 2007
) and neutrophils (Mathias et al., 2006
; Meijer et al., 2007
; Renshaw et al., 2006
) are marked with fluorescent proteins such as green fluorescent protein (GFP). These transgenic zebrafish can be used to provide high-resolution analysis of leukocyte development and trafficking (Mathias et al., 2006
; Redd et al., 2006
), and provide significant insight into the evolution of the inflammatory response. Despite progress in characterizing the zebrafish immune system, no zebrafish models of human chronic inflammatory diseases have been developed to date.
To identify zebrafish models of chronic inflammation, we screened a collection of mutant zebrafish embryos for those that display abnormal tissue distributions of neutrophils. A recent large-scale insertional mutagenesis project (Amsterdam et al., 1999
) produced a collection of mutant zebrafish whose mutations can be mapped relatively quickly when compared to traditional approaches. Several of these mutants have been mapped and display morphological phenotypes that can be viewed within 5 days post-fertilization (dpf) (Amsterdam et al., 2004
). In this study we show that one of these mutants, bearing an insertion within the hepatocyte growth factor activator inhibitor 1 (hai1; also known as spint1) gene, exhibits a phenotype similar to chronic inflammation consisting of neutrophil and macrophage infiltration into the fin of the fish.
In mammals HAI1 has been shown to be a cell surface-bound serine protease inhibitor that has been shown to limit the activity of hepatocyte growth factor activator (HGFA) (Shimomura et al., 1997
) and matriptase (Benaud et al., 2001
), and is required for mouse development (Fan et al., 2006
; Tanaka et al., 2005
). Hepatocyte growth factor (HGF) is a mitogen for several cell types, and is activated (potentially by HGFA and other proteases) at sites of tissue injury (Miyazawa et al., 1994
). Matriptase 1 (also known as ST14) is a type II transmembrane serine protease originally isolated from breast cancer cells and shown to degrade extracellular matrix proteins (Shi et al., 1993
). Matriptase can also proteolytically activate HGF and urokinase-type plasminogen activator (Lee et al., 2000
). Overexpression of matriptase in mouse skin cells causes spontaneous squamous cell carcinoma and other phenotypes consistent with malignant epithelial transformation, including dermal inflammation (List et al., 2005
).
Here we show that hai1 mutant zebrafish embryos exhibit inflammation in areas of epidermal hyperproliferation, a phenotype that resembles the common human skin disease psoriasis. Using time-lapse fluorescent microscopy of optically transparent mutant embryos that express GFP in neutrophils, we tracked the migration of individual neutrophils within the inflamed epithelium. We found that neutrophils in the inflamed fin display a biased random migration with frequent pauses. The mutant phenotype can be rescued by knock-down of Matriptase 1, suggesting that Matriptase 1 is a key effector downstream of Hai1 that regulates epidermal proliferation and inflammation. This study illustrates the utility of zebrafish as a new model system to study chronic inflammation and to visualize immune responses with high resolution in real-time.
|
| Results |
|---|
|
|
|---|
Inflammation is an early component of the hi2217 mutant phenotype
To determine the developmental progression of inflammation in the mutant embryos, we characterized the phenotype at different developmental stages. At 26 hpf at the onset of the epithelial phenotype, we did not observe neutrophil mislocalization by either immunofluorescence or in situ hybridization (data not shown), probably due to the fact that few neutrophils are present at 26 hpf (Lieschke et al., 2001
). By contrast, when we used a macrophage-specific L-plastin antibody (Fig. S1A-C in supplementary material) we found that macrophages are recruited to the areas of rounded cells in mutant embryos at 26 hpf (supplementary material Fig. S1D'). These findings suggest that inflammation is an early component of the phenotype in the hai1 mutant fish.
To determine the onset of neutrophilic inflammation within the tailfin, we used a neutrophil-specific antibody that labels MPO (Mathias et al., 2006
). Zebrafish neutrophils can be detected in the fins of mutant but not control embryos as early as 36 hpf (Fig. 2B,B') and accumulate in areas with rounding of tailfin cells (Fig. 2A,A'). By 48 hpf the tailfins of hi2217 mutant embryos are thinner, appear degraded (Fig. 3A') and are fully infiltrated by neutrophils (Fig. 3B') and macrophages (Fig. 3C'). The infiltration of neutrophils and macrophages into the tailfin persists at 5 dpf (data not shown). The areas of the fin that exhibit neutrophilic infiltration do not appear to have enhanced apoptosis (Fig. 2C,C'). Prevention of apoptosis by injection of a morpholino oligonucleotide (MO) to p53 (Langheinrich et al., 2002
) or treatment with a caspase inhibitor (Renshaw et al., 2006
) had no significant effect on the neutrophilic inflammation in the zebrafish fin at 2 dpf (data not shown). Together these findings suggest that the neutrophilic inflammation into the tailfins of hi2217 mutants is not induced by apoptosis.
|
|
Mutant embryos exhibit enhanced epidermal proliferation and disruption of the epithelial morphology
To further characterize the epithelial phenotype in the mutant embryos we characterized cell proliferation and integrity of epithelial cell-cell contacts in mutant and control embryos. Since areas in the fin that displayed cell rounding and a less differentiated phenotype were not associated with apoptosis, we determined whether cell proliferation was different in mutant and control embryos. The mutant fins exhibited enhanced cell proliferation (detected by BrdU labeling; Fig. 3D', Fig. 4C'), suggesting that the mutant phenotype is associated with hyperproliferation of tailfin cells, which are primarily epithelial in nature. These findings are in accordance with a recent publication that indicates that disruption of Hai1-regulated processes induces epidermal proliferation (List et al., 2005
). Cell borders were labeled using a pan-cadherin antibody, which showed that the normal epithelial organization of tailfin cells (Fig. 3E) was disorganized with overlapping cells in mutant embryos (Fig. 3E'). Together these findings suggest that mutant embryos display epithelial hyperproliferation coupled with inflammation, a phenotype that resembles the common skin condition psoriasis.
|
MO-mediated knock-down of hai1 reproduces the hi2217 mutant phenotype
To confirm that Hai1 mediates the inflammation and epithelial phenotypes observed in mutant embryos, we used a MO to zebrafish hai1 to deplete embryos of Hai1. Injection of the hai1 MO into wild-type embryos was observed to recapitulate the phenotypes observed in the hi2217 mutants (Fig. 5A'-C'), whereas injection of either a standard control MO or 5-base mismatch MO had no effect (Fig. 5A-C). In hai1 morphants at 24 hpf rounded cells over the yolk sac extension were observed (Fig. 5A'), as well as tailfin degradation (Fig. 5B'), and by 48 hpf, the infiltration of neutrophils (Fig. 5C') and macrophages (data not shown) into tailfins. To determine the effect of knocking down hai1 expression in a subset of embryonic cells, we injected the hai1 MO into single cells at the 8- to 16-cell stage of embryonic development to asymmetrically distribute the MO. At 2 dpf these embryos often exhibited localized manifestations of rounded cell clusters in an otherwise morphologically wild-type embryo (Fig. 5D), whereas embryos similarly injected with the 5-base mismatch hai1 MO retained the wild-type morphology (data not shown). Neutrophils were recruited to these localized regions of cell rounding (Fig. 5E) in hai1 morphants, suggesting that changes in the localized environment, induced by reduction of Hai1, induce both the epithelial phenotype and leukocyte recruitment. These data, in conjunction with the hai1 in situ hybridization data (Fig. 1F-G'), indicate that loss of Hai1 results in the observed hi2217 mutant phenotypes.
|
|
Time-lapse imaging of neutrophil inflammation in vivo
To generate a model in which neutrophil motility could be observed in a chronic inflammatory state, the hi2217 line was crossed to a transgenic line (MPO:GFP) in which neutrophils express GFP (Mathias et al., 2006
). Time-lapse microscopy of hi2217;MPO:GFP mutant embryos at 2 dpf showed extensive infiltration of highly motile neutrophils into mutant tailfins (see Movie 1 in supplementary material). Individual neutrophils were tracked (Fig. 7A) and basic parameters of cell migration were analyzed for long durations (average 82 minutes). The average cell speed was 6.5±2.2 µm/minute and the cells exhibited low directional persistence over extended durations, with a D/T ratio of 0.27 (D/T>0.7 considered directed migration). Individual neutrophil migration was characterized by periods of motility alternating with frequent pauses (Fig. 7B,C), similar to what is observed in migrating primordial germ cells, which exhibit frequent pauses or `tumbling' modes alternating with periods of rapid migration or `running' (Reichman-Fried et al., 2004
). These behavioral modes in hi2217 neutrophils appeared to be independent of the cellular environment since individual neutrophils did not share common tracks and cells generally did not simultaneously accumulate in specific areas. During active migration hi2217 neutrophils take on a highly polarized morphology and were often very protrusive (Fig. 7B-D, Movie 2 in supplementary material), whereas pauses were characterized by a loss of polarity, cell rounding and extension of pseudopodia in multiple directions (Fig. 7B-D). Mutant neutrophils were observed to pause frequently (moving <0.75 µm/minute, for an average of 16% of the time; see Fig. 7E), and cells that paused more frequently were found to have lower average velocities (Fig. 7E). When analyzed over 15-minute windows, periods of directional migration with intervening periods of random movement were often apparent (Fig. 7F-I). Whereas some tracks showed correlation between changes in velocity and directional persistence (Fig. 7F,G), others showed that there was no significant correlation between these parameters (Fig. 7H,I). Some migratory GFP-positive cells in the mutants were observed to undergo mitosis, with continued migration after cell division (Movie 1 in supplementary material). Since neutrophils are terminally differentiated cells, this probably indicates that neutrophil precursors [which express zMPO (Hsu et al., 2004
; Lieschke et al., 2001
)] are contributing to the inflammatory response in mutants, which emphasizes the severity of the mutant phenotype. In summary, zebrafish neutrophils exhibit highly dynamic motility in the context of chronic inflammation in vivo, characterized by periods of rapid movement alternating with stopping or pausing.
|
|
Effect of NS-398 on neutrophil motility in vivo
To determine the utility of the hi2217;MPO:GFP model to test the effects of specific drug treatments on motility and inflammatory responses in vivo, we tested the effects of a non-steroidal inhibitor of cyclooxygenase-2 (COX-2; also known as Ptgs2a), NS-398, on neutrophil motility in vivo. COX-2 expression is induced at sites of inflammation and produces pro-inflammatory prostaglandins that can be inhibited by NS-398 in animal models, thereby reducing inflammation (Masferrer et al., 1994
). NS-398 has been shown to suppress cytokine release (Kimura et al., 2003
) and accelerate Fas-mediated apoptosis (Iwase et al., 2006
) in human neutrophils, but to our knowledge its effect on neutrophil migration has not been studied. Mutant embryos incubated in 250 µM NS-398 for 1 hour were observed by time-lapse microscopy in the presence of the drug and after washout. In the presence of NS-398, neutrophil motility was impaired substantially (Fig. 9A,B and Movie 3 in supplementary material). However, migration was rescued after washout of the drug (Fig. 9C and Movie 3 in supplementary material). There was no evidence of neutrophil apoptosis, however, we observed some reduction in heart rate during drug treatment that resolved after washout (data not shown). These findings indicate that the hi2217;MPO:GFP zebrafish will be an important tool to assess the effect of inflammatory modulators on neutrophil function in vivo.
|
| Discussion |
|---|
|
|
|---|
Recent studies in mouse models highlight the importance of a balance between Matriptase 1 and Hai1 activity in the progression of epithelial tumors. Dysregulated Matriptase 1 is associated with carcinogenesis and promotes malignant transformation that can be blocked by overexpression of Hai1 in the epidermis (List et al., 2005
), suggesting that inhibition of Matriptase 1 may be an attractive target to treat epithelial cancers that are associated with increased Matriptase 1 activity. The hai1 transgenic zebrafish represents an attractive model to further study the role of Hai1-Matriptase 1 in epithelial hyperproliferation and the generation of inflammation. Inhibition of Matriptase 1 blocks the hi2217 mutant phenotype (Fig. 6), providing further support for the utility of this system to understand the relationship between Hai1 and Matriptase 1 in epithelial morphogenesis and inflammation. Furthermore, the transgenic zebrafish model provides a powerful tool to screen for agents that block both the epithelial and inflammatory phenotypes, thereby having therapeutic potential for both inflammatory disease and cancer. The relevance of the zebrafish model to disease models in mice and humans further provides support for the utility of zebrafish genetic screens to identify pathways that regulate the development of chronic inflammation.
The common human skin condition psoriasis is characterized by epithelial proliferation, lack of differentiation and inflammation of the skin (Bowcock and Krueger, 2005
; Lowes et al., 2007
). The inflammatory infiltrate in psoriasis is often mixed and frequently contains neutrophils. Other inflammatory skin diseases are characterized by a predominantly neutrophilic infiltrate include Sweet syndrome (Wallach and Vignon-Pennamen, 2006
) and the autoinflammatory disease neonatal onset multisystem inflammatory disease (NOMID) (Huttenlocher et al., 1995
). The phenotype of the hai1 mutant zebrafish resembles psoriatic disease in that the mutant fish display hyperproliferation of epithelial cells and chronic inflammation. There is a long-standing controversy about whether psoriasis is a primary disease of the keratinocytes or the immune system. Substantial evidence suggests that psoriasis can be a primary disease of keratinocytes, in that changes in gene expression in keratinocytes specifically induces psoriatic disease in mouse models. For example, ectopic expression of beta 1 integrin in mouse keratinocytes induces a disease characterized by keratinocyte hyperproliferation and inflammation with both T cells and neutrophils (Carroll et al., 1995
). Our findings further support the importance of primary changes in epithelial function in the pathogenesis of inflammation in the zebrafish fin, as depletion of both neutrophils and macrophages in zebrafish embryos did not block the early morphological phenotypes in hi2217 mutants (Fig. 4 and supplementary material Fig. S1G'). Further support for a role of the epithelium in orchestrating the inflammatory response in the skin is provided by the production of inducible nitric oxide and IL-8 by epithelial cells in psoriatic lesions (Bruch-Gerharz et al., 1996
) that would provide the inflammatory milieu required for the recruitment of neutrophils and other inflammatory cells. Taken together, these findings support the utility of zebrafish inflammation models as systems to study the pathogenesis of epithelial proliferative disorders and their relationship to inflammation. Further studies may help to elucidate the relationship between epithelial phenotypes and inflammation and the development of targets that help to mitigate disease progression.
Whereas the activities of immune cells in normal or tumor contexts have been studied (Bajenoff et al., 2006
; Mrass et al., 2006
), few studies have addressed the dynamic movement of leukocytes in the context of chronic inflammation in vivo. The zebrafish system represents a powerful model to study the movement of leukocytes in real-time in response to both acute and chronic inflammatory stimuli. Our recent study using zebrafish that express GFP in neutrophils (Mathias et al., 2006
) identified a unique mechanism of directional neutrophil trafficking betweens sites of tissue injury and the vasculature, and implicated a novel mechanism of retrograde chemotaxis from wound sites back toward the vasculature in the resolution phase of the inflammatory response. Furthermore, in the context of acute injury we also observed the simultaneous directed migration of individual neutrophils both toward and away from wound sites, suggesting that neutrophils independently respond to signals in an inflammatory context. Using the hi2217;MPO:GFP mutant zebrafish, we now demonstrate that in the context of chronic inflammation, zebrafish neutrophils displayed a relatively more random migration within the zebrafish fin, an apparent `random walk' (Fig. 8C) without clear movement toward or away from the vasculature. Analysis of hai1 mutant cell tracking data indicated that whereas some neutrophils moved in a random manner others demonstrated the ability to move in a directional manner for short periods (Fig. 7A,F-I, Fig. 8B) indicating that neutrophils can probably still process and respond to directional signals within an area of chronic inflammation. Accordingly, neutrophils retained the ability to respond to a wound in the mutant embryos. Taken together with our previous observation of directed retrograde migration, the findings suggest that neutrophils in the mutant embryos may still be able to respond to signals that would draw them away from the chronically inflamed area, which presents potential therapeutic applications.
The hai1 mutant zebrafish embryos displayed diffuse inflammation within the fin by 2 dpf, without aggregates of neutrophils or apparent organization to the inflammatory response. This feature enabled long-term cell tracking of individual neutrophils, with many tracks several hours in length, and created a great advantage for further analysis of cell tracking parameters in vivo (Fig. 7E-I). Although the neutrophils were highly dynamic they frequently exhibited periods of stopping within the zebrafish fin and then subsequent periods of motility (Fig. 7A-C), similar to what has been observed for migrating primordial germ cells (Reichman-Fried et al., 2004
). This stopping and starting appeared to be neutrophil-specific and not secondary to localized changes within the extracellular environment, as neutrophils did not aggregate within a specific region of the mutant fin. Upon pausing, neutrophils take on an unpolarized, rounded morphology (Fig. 7B,C) similar to what we have observed when neutrophils stop at a site of tissue injury (Mathias et al., 2006
), suggesting that cells within hi2217 mutant tailfins are producing similar signals that cause neutrophils to arrest. During pauses neutrophils were often observed to extend pseudopodia in multiple directions and then resume migration (Fig. 7B,C), indicating that they are processing multiple directional cues while stopped. Interestingly, treatment with the non-steroidal COX-2 inhibitor NS-398 also induced neutrophils to pause and take on this rounded morphology (Fig. 9A and Movie 3 in supplementary material). Since COX-2 is involved in the production of pro-inflammatory prostaglandins at sites of inflammation, our findings suggest that these inflammatory mediators regulate neutrophil recruitment and migration in vivo. The exact nature of the immune components that trigger the rapid and random motility of neutrophils within the context of this chronic inflammation model remain unknown, however, it likely involves a complex interplay between soluble and extracellular matrix components that impact the inflammatory response. This will be a challenge for future investigations to dissect the molecular architecture of the chronic inflammatory milieu in vivo.
| Materials and Methods |
|---|
|
|
|---|
hi2217/spint1
+) were crossed to Tg(MPO:GFP)uw (Mathias et al., 2006
Image acquisition
Images were captured with either (1) a Nikon SMZ-1500 zoom microscope equipped with epifluorescent illumination (GFP: Ex 470/40, BA 525/50; DsRed: Ex 545/30, BA 525/50), a CoolSnap ES camera (Roper Scientific), and a Digital Sight DS-Fi1 color camera (Nikon); or (2) a Nikon Eclipse TE300 inverted microscope equipped with 20x (NA 0.45), 40x (NA 0.75) and 60x (NA 1.40) DIC objectives, epifluorescent illumination (Ex 480/25, Em 525/40) and a Hamamatsu Orca II CCD camera. For movies, embryos were embedded in 1% low-melting point agarose and maintained in E3 medium containing 0.1 mg/ml Tricaine at 30°C, unless otherwise noted. Color images were captured with NIS Elements D 2.30 software, all other images were captured and analyzed with MetaMorph software. Movies were converted to AVI format using MetaMorph and compressed using QuickTime Player version 7.0.4.
Whole-mount in situ hybridization
The Hopkins mutant zebrafish collection (Amsterdam et al., 1999
) was screened for expression of zMPO by in situ hybridization (J.R., unpublished data). Briefly, embryos were obtained from crosses of adults known to be heterozygous for individual insertions, raised in E3 medium containing 0.2 mM N-phenylthiourea and fixed at 2 dpf in 4% paraformaldehyde in PBS; zMPO mRNA was labeled by in situ hybridization as described previously (Bennett et al., 2001
). Zebrafish hai1 mRNA expression was detected by the same protocol using probe cb376 (accession # BU492960) as done previously (Thisse et al., 2001
). Zebrafish Matriptase 1 was detected using IMAGE clone # 5618275 (obtained from ATCC), a partial cDNA in pBluescript SK– that was digested with either XhoI or EcoRI to generate templates for sense and antisense probes, respectively.
Zebrafish embryo sectioning
Embryos were fixed as above, washed in PBS, suffused in 30% sucrose and infiltrated with paraffin. Paraffin sections, 5 µm thick, were processed and stained with Hematoxylin and Eosin as described previously (Hsu et al., 2004
). Whole-mount in situ-labeled embryos were fixed and suffused in sucrose as above, embedded in OCT and cryosectioned at 10 µm.
Whole-mount immunolabeling, TUNEL and BrdU labeling
Zebrafish embryos were fixed in 4% paraformaldehyde in PBS overnight at 4°C and immunolabeled as described previously (Mathias et al., 2006
). Polyclonal antibodies to zebrafish L-plastin as were raised in rabbits following injection of a GST-L-plastin fusion protein (the plasmid construct was a gift from Paul Martin, University of Bristol, UK) and purified as described previously (Bennin et al., 2002
). Cadherins were labeled using a polyclonal rabbit anti-Pan-Cadherin IgG (Sigma), which has previously been done in zebrafish (Bitzur et al., 1994
; Crawford et al., 2003
). Apoptotic cells were fluorescently labeled by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) using a Roche kit (catalog # 12156792910) as follows: after immunolabeling, embryos were washed in PBS, placed on ice in 50 µl 1x reaction mix for 1 hour, incubated at 37°C for 1 hour with periodic mixing and washed as in the immunolabeling protocol. Proliferating cells were labeled by incubating embryos in 10 mM 5-bromo-deoxyuridine (BrdU) in E3 for 20 minutes (Dekens et al., 2003b
); embryos were then washed in E3, fixed and processed as described for immunolabeling, except that following rehydration from methanol embryos were treated with 4 M HCl for 20 minutes (Dekens et al., 2003a
) and washed in PBS several times. BrdU-labeled cells were detected with a monoclonal antibody to BrdU (Sigma, clone BU33) and a Rhodamine Red-conjugated goat anti-mouse antibody (Molecular Probes).
Morpholino oligonucleotide microinjection
Morpholino oligonucleotides (MO) were purchased from GeneTools, LLC (Philomath, OR, USA) and resuspended 1x Danieau buffer to a stock concentration of 1 mM, according to the manufacturer's protocols. MO were further diluted in 1x Danieau buffer and injected (amounts indicated below with each individual MO) into the yolk of 1- to 4-cell stage embryos; control MO were injected at the same (or greater) volume and concentration. Standard control MO sequence is available from GeneTools, pu.1 (1 nl at 1 mM injected) and p53 (1 nl at 1 mM) MO sequences were as described previously (Langheinrich et al., 2002
; Rhodes et al., 2005
). Other MO sequences were designed to block translation (hai1: accession no. BC053239; matriptase 1: accession no. XM_678577) and are as follows (5'-3'): hai1 (0.5 nl at 35 µM) – CTGAGTTGAGCCAGAGTCATCCTCC hai1, 5-base mismatch – CTcAGTTcAGCCAcAGTgATgCTCC matriptase 1 MO1 (0.2-0.5 nl at 0.3 mM) – GCATTCCTCCATCCATAGGGTCCAT matriptase 1 MO1, 5-base mismatch – GCATTgCTCgATgCATAcGGTCgAT matriptase 1 MO2 (0.4-0.5 nl at 0.3 mM) – CCACTGGCAGAATCAAAATCA-ACAC.
For injection into 8- to 16-cell embryos (Fig. 5D,E), either the hai1 or 5-base mismatch hai1 MO was diluted to 0.65 µM in 1x Danieau along with 5 mg/ml tetramethyl Rhodamine-conjugated dextran (MW=10,000; Molecular Probes) as a cell tracer; 66 pl was then injected into single cells. For partial knock-down of matriptase 1 (Fig. 6K,L), 0.25 nl of 0.3 mM matriptase 1 MO2 were injected into the yolk of hi2217 embryos.
Cell tracking and analysis
Neutrophils from hi2217;MPO:GFP embryos were tracked and analyzed as described previously (Mathias et al., 2006
); data were collected from three movies for both mutant embryos and wild-type siblings with wounded tailfins. For Fig. 7, tracks in mutants include all data points in which an individual cell can be distinguished from other cells. To derive percentage time stopped (Fig. 7E), values for each overall mutant cell track, the number of data points in which the distance traveled was less than 0.75 µm was divided by the total data time points. For the analysis in Fig. 7F-I velocity and D/T values were determined for successive 15-minute intervals of the track with 1 minute between each interval, i.e. parameters for interval 1 were derived from coordinates at time points t1=1 minute and t2=15 minutes, interval 2 from t1=2 minutes and t2=16 minutes, and so on until the end of the track. For comparison of wild-type cell tracks to the significantly longer overall mutant cell tracks, the average length of wild-type cell tracks to wounds was determined to be 12 minutes; therefore the first 12 minutes of each mutant cell track (starting at the onset of migration) was taken and parameters were derived for Fig. 8A,B. For Fig. 8C, the first 8.5 minutes of individual tracks (starting at the onset of migration, omitting pauses that start some tracks) were used to calculate mean displacement values (Sumen et al., 2004
).
NS-398 drug treatment
Mutant embryos were washed in E3 containing 0.1% DMSO and 0.2% BSA (E3++), then incubated for 1 hour at room temperature in E3++ supplemented with either 250 µM NS-398 (purchased either from Sigma or Cayman Chemical and resuspended at 5 mg/ml in DMSO) or 1.5% DMSO (as a vehicle control). Tricaine was then added to a final concentration of 0.1 mg/ml and movies were captured as detailed above, except that embryos were not embedded in agarose. Imaged embryos were then washed several times in E3++ and allowed to recover for 1 hour, followed by further imaging of the same embryos.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Amsterdam, A., Burgess, S., Golling, G., Chen, W., Sun, Z., Townsend, K., Farrington, S., Haldi, M. and Hopkins, N. (1999). A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 13, 2713-2724.
Amsterdam, A., Nissen, R. M., Sun, Z., Swindell, E. C., Farrington, S. and Hopkins, N. (2004). Identification of 315 genes essential for early zebrafish development. Proc. Natl. Acad. Sci. USA 101, 12792-12797.
Bajenoff, M., Egen, J. G., Koo, L. Y., Laugier, J. P., Brau, F., Glaichenhaus, N. and Germain, R. N. (2006). Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25, 989-1001.[CrossRef][Medline]
Benaud, C., Dickson, R. B. and Lin, C. Y. (2001). Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur. J. Biochem. 268, 1439-1447.[Medline]
Bennett, C. M., Kanki, J. P., Rhodes, J., Liu, T. X., Paw, B. H., Kieran, M. W., Langenau, D. M., Delahaye-Brown, A., Zon, L. I., Fleming, M. D. et al. (2001). Myelopoiesis in the zebrafish, Danio rerio. Blood 98, 643-651.
Bennin, D. A., Don, A. S., Brake, T., McKenzie, J. L., Rosenbaum, H., Ortiz, L., DePaoli-Roach, A. A. and Horne, M. C. (2002). Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J. Biol. Chem. 277, 27449-27467.
Bitzur, S., Kam, Z. and Geiger, B. (1994). Structure and distribution of N-cadherin in developing zebrafish embryos: morphogenetic effects of ectopic over-expression. Dev. Dyn. 201, 121-136.[Medline]
Bowcock, A. M. and Krueger, J. G. (2005). Getting under the skin: the immunogenetics of psoriasis. Nat. Rev. Immunol. 5, 699-711.[CrossRef][Medline]
Bruch-Gerharz, D., Fehsel, K., Suschek, C., Michel, G., Ruzicka, T. and Kolb-Bachofen, V. (1996). A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J. Exp. Med. 184, 2007-2012.
Carroll, J. M., Romero, M. R. and Watt, F. M. (1995). Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83, 957-968.[CrossRef][Medline]
Crawford, B. D., Henry, C. A., Clason, T. A., Becker, A. L. and Hille, M. B. (2003). Activity and distribution of paxillin, focal adhesion kinase, and cadherin indicate cooperative roles during zebrafish morphogenesis. Mol. Biol. Cell 14, 3065-3081.
Crowhurst, M. O., Layton, J. E. and Lieschke, G. J. (2002). Developmental biology of zebrafish myeloid cells. Int. J. Dev. Biol. 46, 483-492.[Medline]
Davis, J. M., Clay, H., Lewis, J. L., Ghori, N., Herbomel, P. and Ramakrishnan, L. (2002). Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17, 693-702.[CrossRef][Medline]
de Jong, J. L. and Zon, L. I. (2005). Use of the zebrafish system to study primitive and definitive hematopoiesis. Annu. Rev. Genet. 39, 481-501.[CrossRef][Medline]
Dekens, M. P., Pelegri, F. J., Maischein, H. M. and Nusslein-Volhard, C. (2003a). The maternal-effect gene futile cycle is essential for pronuclear congression and mitotic spindle assembly in the zebrafish zygote. Development 130, 3907-3916.
Dekens, M. P., Santoriello, C., Vallone, D., Grassi, G., Whitmore, D. and Foulkes, N. S. (2003b). Light regulates the cell cycle in zebrafish. Curr. Biol. 13, 2051-2057.[CrossRef][Medline]
Fan, B., Brennan, J., Grant, D., Peale, F., Rangell, L. and Kirchhofer, D. (2006). Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth. Dev. Biol. 303, 222-230.[CrossRef][Medline]
Hall, C., Flores, M. V., Storm, T., Crosier, K. and Crosier, P. (2007). The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC Dev. Biol. 7, 42.[CrossRef][Medline]
Hsu, K., Traver, D., Kutok, J. L., Hagen, A., Liu, T. X., Paw, B. H., Rhodes, J., Berman, J. N., Zon, L. I., Kanki, J. P. et al. (2004). The pu.1 promoter drives myeloid gene expression in zebrafish. Blood 104, 1291-1297.
Huttenlocher, A., Frieden, I. J. and Emery, H. (1995). Neonatal onset multisystem inflammatory disease. J. Rheumatol. 22, 1171-1173.[Medline]
Iwase, M., Takaoka, S., Uchida, M., Kondo, G., Watanabe, H., Ohashi, M. and Nagumo, M. (2006). Accelerative effect of a selective cyclooxygenase-2 inhibitor on Fas-mediated apoptosis in human neutrophils. Int. Immunopharmacol. 6, 334-341.[CrossRef][Medline]
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253-310.[Medline]
Kimura, T., Iwase, M., Kondo, G., Watanabe, H., Ohashi, M., Ito, D. and Nagumo, M. (2003). Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils. Int. Immunopharmacol. 3, 1519-1528.[CrossRef][Medline]
Langenau, D. M. and Zon, L. I. (2005). The zebrafish: a new model of T-cell and thymic development. Nat. Rev. Immunol. 5, 307-317.[CrossRef][Medline]
Langenau, D. M., Ferrando, A. A., Traver, D., Kutok, J. L., Hezel, J. P., Kanki, J. P., Zon, L. I., Look, A. T. and Trede, N. S. (2004). In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc. Natl. Acad. Sci. USA 101, 7369-7374.
Langheinrich, U., Hennen, E., Stott, G. and Vacun, G. (2002). Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr. Biol. 12, 2023-2028.[CrossRef][Medline]
Lee, S. L., Dickson, R. B. and Lin, C. Y. (2000). Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275, 36720-36725.
Lieschke, G. J., Oates, A. C., Crowhurst, M. O., Ward, A. C. and Layton, J. E. (2001). Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 98, 3087-3096.
List, K., Szabo, R., Molinolo, A., Sriuranpong, V., Redeye, V., Murdock, T., Burke, B., Nielsen, B. S., Gutkind, J. S. and Bugge, T. H. (2005). Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev. 19, 1934-1950.
Lowes, M. A., Bowcock, A. M. and Krueger, J. G. (2007). Pathogenesis and therapy of psoriasis. Nature 445, 866-873.[CrossRef][Medline]
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C. and Seibert, K. (1994). Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228-3232.
Mathias, J. R., Perrin, B. J., Liu, T. X., Kanki, J., Look, A. T. and Huttenlocher, A. (2006). Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukoc. Biol. 80, 1281-1288.
Meijer, A. H., van der Sar, A. M., Cunha, C., Lamers, G. E., Laplante, M. A., Kikuta, H., Bitter, W., Becker, T. S. and Spaink, H. P. (2007). Identification and real-time imaging of a myc-expressing neutrophil population involved in inflammation and mycobacterial granuloma formation in zebrafish. Dev. Comp. Immunol. May 22 [Epub ahead of print] doi: 10.1016/j.dci.2007.04.003
Miyazawa, K., Shimomura, T., Naka, D. and Kitamura, N. (1994). Proteolytic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem. 269, 8966-8970.
Mrass, P., Takano, H., Ng, L. G., Daxini, S., Lasaro, M. O., Iparraguirre, A., Cavanagh, L. L., von Andrian, U. H., Ertl, H. C., Haydon, P. G. et al. (2006). Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J. Exp. Med. 203, 2749-2761.
Murayama, E., Kissa, K., Zapata, A., Mordelet, E., Briolat, V., Lin, H. F., Handin, R. I. and Herbomel, P. (2006). Tracing hematopoietic precursor migration to successive hematopoietic organs during zebrafish development. Immunity 25, 963-975.[CrossRef][Medline]
Nusslein-Volhard, C. and Dahm, R. (2002). Zebrafish, A Practical Approach. New York: Oxford University Press.
Oberst, M., Anders, J., Xie, B., Singh, B., Ossandon, M., Johnson, M., Dickson, R. B. and Lin, C. Y. (2001). Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am. J. Pathol. 158, 1301-1311.
Onnebo, S. M., Yoong, S. H. and Ward, A. C. (2004). Harnessing zebrafish for the study of white blood cell development and its perturbation. Exp. Hematol. 32, 789-796.[CrossRef][Medline]
Patton, E. E. and Zon, L. I. (2001). The art and design of genetic screens: zebrafish. Nat. Rev. Genet. 2, 956-966.[CrossRef][Medline]
Redd, M. J., Kelly, G., Dunn, G., Way, M. and Martin, P. (2006). Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation. Cell Motil. Cytoskeleton 63, 415-422.